These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9041479)

  • 21. Screening for hereditary haemochromatosis should be implemented now.
    Allen K; Williamson R
    BMJ; 2000 Jan; 320(7228):183-4. PubMed ID: 10634748
    [No Abstract]   [Full Text] [Related]  

  • 22. [The value of iron determination. Comment on Hermann Heimpel, Martin Riedel, Roman Wennauder, Lothar Thomas: Plasma iron determination--useful, unnecessary or misleading?].
    Teich N; Mossner J
    Med Klin (Munich); 2003 Jul; 98(7):398-9. PubMed ID: 14723238
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA-A3 and serum iron. A study in an Irish control population.
    Stevens FM; Fallon MG; McCarthy CF; Grimes H
    Tissue Antigens; 1983 May; 21(5):402-4. PubMed ID: 6868061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary haemochromatosis.
    Janssen MC; Swinkels DW
    Best Pract Res Clin Gastroenterol; 2009; 23(2):171-83. PubMed ID: 19414144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of hemochromatosis.
    O'Neil J; Powell L
    Semin Liver Dis; 2005 Nov; 25(4):381-91. PubMed ID: 16315132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: targeted screening for hereditary haemochromatosis in high-risk groups.
    DuBois S; Kowdley KV
    Aliment Pharmacol Ther; 2004 Jul; 20(1):1-14. PubMed ID: 15225165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary haemochromatosis.
    Edwards CQ; Dadone MM; Skolnick MH; Kushner JP
    Clin Haematol; 1982 Jun; 11(2):411-35. PubMed ID: 7042159
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemochromatosis: the importance of mutation screening in the family].
    ter Braak N; Erdkamp FL; van Deursen CT
    Ned Tijdschr Geneeskd; 2009 Apr; 153(16):765-7. PubMed ID: 19469149
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic hemochromatosis: distribution analysis of six laboratory measures of iron metabolism.
    Borecki IB; Rao DC; Le Mignon L; Yaouanq J; Simon M; Lalouel JM
    Am J Med Genet; 1989 Nov; 34(3):435-41. PubMed ID: 2596531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemochromatosis: the need for an agreed case definition.
    Patch C; Roderick P; Rosenberg W
    J Hepatol; 2005 Nov; 43(5):911. PubMed ID: 16171894
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemochromatosis.
    Adams PC; Barton JC
    Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cascade testing of primary care blood samples with hyperferritinaemia identifies subjects with iron overload and porphyria cutanea tarda.
    Baddams EL; Degg T; Barth JH
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):499-502. PubMed ID: 24081184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-transferrin-bound iron in 4 patients with excessive amounts of iron in the blood].
    Vernet-Nyssen M; Abramian S; Girard D; Bel A
    Nouv Presse Med; 1982 Dec; 11(50):3725-6. PubMed ID: 7170173
    [No Abstract]   [Full Text] [Related]  

  • 39. Iron metabolism during treatment of idiopathic haemochromatosis.
    MACGREGOR AG; RAMSAY WN
    Lancet; 1957 Dec; 273(7009):1314-6. PubMed ID: 13492635
    [No Abstract]   [Full Text] [Related]  

  • 40. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.